Metraipolis › archive › dc_6d50daebc9fe
An Overview of the Factors Related to Leishmania Vaccine Development — Europe PMC PMID:41600970
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41600970
- DOI
- 10.3390/vaccines14010054
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:38:20.830Z
- SHA-256 of the archived text
5234499f312984f299a09356ceeab02aed3698dfa83595ceec128e8222ae63b7- Stable URL of this page
https://metraipolis.com/documento/dc_6d50daebc9fe
How to cite
An Overview of the Factors Related to Leishmania Vaccine Development — Europe PMC PMID:41600970 — Europe PMC (en), https://europepmc.org/article/MED/41600970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d50daebc9fe (Metraipolis archive dc_6d50daebc9fe, sha256 5234499f312984f299a09356ceeab02aed3698dfa83595ceec128e8222ae63b7)
BibTeX
@misc{dc6d50daebc9fe,
title = {An Overview of the Factors Related to Leishmania Vaccine Development — Europe PMC PMID:41600970},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41600970},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d50daebc9fe; sha256 5234499f312984f299a09356ceeab02aed3698dfa83595ceec128e8222ae63b7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41600970. Agents can read the archived copy with the MCP tool read_document.